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Abstract
Background: The rising challenge of diabetes requires novel service delivery approaches. In the UK, Local
Enhanced Services (LES) have been commissioned for diabetes. Health professionals from general practices (GPs)
who signed up to LES were given additional training (and a monetary incentive) to improve management of patients
with diabetes. All practices in the PCT were invited to the LES initiative, which ensured avoiding selection bias. The
aim of the study was to examine the impact of LES in terms of diabetes Quality Outcome Framework (QOF)
indicators: DM23(glycaemia), DM17(lipid) and DM12(blood pressure; BP).
Methods: QOF diabetes indicators were examined using data from 76 general practices for 2009–2010 in a large
primary care trust area in Birmingham, UK. Data were extracted from Quality Management Analysis System. The
primary outcome was a difference in achievement of QOF indicators between LES and NLES practices. A secondary
outcome was the difference between LES and non-LES practices for hospital first and follow-up appointments.
Results: We did not find any difference for DM12(BP) and DM17(lipid) outcomes between LES and NLES practices.
However, LES practices were more likely to achieve the DM23(glycaemia) outcome (estimated odds 1.459;95% CI:
1.378-1.544; P=0.0001). The probability of achieving satisfactory level of DM23(glycaemia) increased by almost 10%
when GPs belonged to LES groups compared with GPs in NLES group. LES practices were less likely to refer
patients to secondary care.
Conclusion: Overall, LES practices performed better in the achievement of DM23(glycaemia) and also referred
fewer patients to hospital, thereby meeting their objectives. This suggests that the LES approach is beneficial and
needs to be further explored in order to ascertain whether the impact exerted was due to LES.
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Introduction
The prevalence of diabetes mellitus is increasing alarmingly
worldwide. The World Health Organization (WHO) estimates
that over 346 million people have diabetes, and that by 2030,
diabetes will become the 7th leading cause of death worldwide
[1]. The number diagnosed with diabetes in the UK has
increased by nearly 50% since general practices (GPs) first
published diabetes data in 2005 from 130,000 to 2.9 million in
2011 [2]. Diabetes micro- and macro-vascular complications
reduce quality of life, and increase mortality, particularly from
cardiovascular disease [3-5]. Diabetes is a major challenge to
healthcare services worldwide necessitating urgent preventive
action, while providing and developing accessible and effective
evidence-based services to reduce the burden of diabetes.
In April 2004, the UK National Health Service (NHS)
introduced the Quality and Outcomes Framework (QOF; http://
www.qof.ic.nhs.uk/) as part of the General Medical Services
(GMS) contract for UK general practice [6]. The aim was to
improve patient care and service delivery for chronic diseases
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such as diabetes through financial incentives. For diabetes,
there is evidence from major studies that glycemic [7-11], blood
pressure [12-14], and lipid control [15,16] will reduce the risk of
complications. As part of QOF, GPs have been rewarded for
the percentage of patients achieving pre-set glycemic, blood
pressure, and cholesterol level targets.
Given the increasing prevalence of chronic conditions such
as diabetes, further incentivization to general practice was
developed through commissioning of Enhanced Services
aiming to provide a greater range of local services for patients
while reducing pressures on secondary care. For diabetes,
enhanced services would offer the framework and resources
for providing local comprehensive diabetes management within
the practice for appropriate patients, to support self-
management, and to prevent diabetes complications. This
included the appropriate use of the community diabetes team
and secondary care as per the PCT diabetes guidelines and
agreed secondary care referral criteria.
The practices were required to provide, completely in primary
care, the diabetes management for all patients who did not
meet the referral criteria for secondary care. This included
those with Type 2 diabetes controlled with lifestyle alone or oral
hypoglycaemic agents and patients with Type 2 diabetes
requiring insulin treatment and patients with stable Type 1
diabetes.
In order to meet the service aims, the practices were
required to review all patients currently managed in secondary
care, and discharge all patients who do not meet the referral
criteria who were receiving routine diabetes care from
secondary care providers, and provide this care in the practice
(with negotiated support from the community diabetes service).
As part of this, patients were offered dedicated protected
diabetes clinic time at least twice a year, of which one visit was
to be for the annual diabetes needs assessment and
development of the agreed diabetes care and management
plan with the diabetes accredited GP.
The impact of commissioned locally enhanced services
(LES) on diabetes outcomes has not been previously
investigated. We examined the LES impact on QOF diabetes
outcomes in a large UK primary care trust area.
Methods
The study used data from the Quality Management Analysis
System (QMAS) with data extracted from GP patient records.
We examined QOF diabetes indicators using data from 76
practices for full year of collection 2009–2010 from Birmingham
East and North Primary Care Trust (BENPCT, Birmingham,
UK) general practices. In order to identify whether any
achievement was due to LES or a time difference, we
examined available data from 34 Non-LES (NLES) practices in
2004-2005 and in 2009-2010.
Outcome Measures
The primary aim was to investigate the difference between
LES and NLES practices in achieving three QOF outcome
measures:
1. DM12 (blood pressure, BP): Percentage of patients with
diabetes in whom the last blood pressure was ≤
145/85mmHg;
2. DM17 (lipid): Percentage of patients with diabetes
whose last measured total cholesterol within the previous
15months was ≤5mmol/l;
3. DM23 (glycaemia): Percentage of patients with diabetes
in whom the last HbA1c (DCCT aligned) was ≤7% (53
mmol/mol) (or equivalent test/reference range depending
on local laboratory) in the previous 15months.
The secondary outcomes examined were:
1. Changes in achievement of indicators in 2004-2005
(prior to LES) compared to 2009-2010;
2. Hospital attendance for a first or follow-up diabetes
related appointment for 2009–2010.
In 2004-2005, there was no DM23 (glycaemia) indicator. The
equivalent was DM6: percentage of patients with diabetes in
whom the last HbA1C was ≤7.4 % (57 mmol/mol) (or
equivalent test/reference range depending on local laboratory)
in last 15months. The targets set for HbA1c have been more
stringent recently than in 2004-2005. DM6 is, however, the
closest measure to DM23 (glycaemia) available.
Ethics Statement
This study, using practice performance data, was a service
evaluation, and did not need any ethical approval as
recommended by the UK National Research Ethics Service
[17].
Statistical Analyses
All analyses were carried out using the statistics package R.
We used the odds ratio to test significant differences between
LES and NLES practices. This is a measure of association of
the group indicator (GP in LES vs. GP not in LES) with the
occurrence of a given event (achieving the target QOF
outcome) of 76 GPs first. The sampling units we used were the
GP practices rather than individual patients. This helped to
exclude the existence of patient confounding factors such as
patient demographics, differences in the number of years
doctors have been practicing or time of each consultation.
We cross-classified the total number of patients in the LES
and NLES groups by patients who achieved (Positive) vs. the
patients who did not achieve (Negative) the target. This
allowed us to test whether LES practices achieved the targets
more or less than NLES practices.
The group count data were reformatted to individual binary
outcomes. We had adequate sample size of GPs for our
investigations. We therefore did not use power to specify the
sample size.
A sample size of 21,026 patients in 76 GPs were included to
investigate whether LES GPs performed better than NLES GPs
in each of the QOF outcomes and for all outcomes combined.
We used multilevel modeling to measure achievements for
each patient nested within GP practices [18]. Combined
analysis of performance in QOF outcomes was carried out to
understand and evaluate QOF goals and achievements. We
Diabetes Enhanced Service Impact on QOF
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conducted logistic multilevel modeling on the combined
structure of the three outcomes. The practice sizes of each GP
are random as they vary between practices. GP practice size
vanishes when formulating multilevel data structure.
We further explored improvement over time for 34 GPs. A
sample of 34 NLES GPs were used to investigate (4,467
patients at the base time, and 6,253 at comparison) how each
GP practice affects the probability of achieving the target over
two time points in each of the three QOF outcomes, and all
outcomes combined. We used Cochran-Mantel-
Haenszel(CMH) 2X2Xk(k denotes GP, i.e. 34 GP)[19] Chi-
Square to test and estimate the changes over two time points
for DM12 (BP), DM17 (lipid) and DM23 (glycaemia). We then
modeled the changes to the three odds ratio data over the two
time point to investigate the change over time [19]. The GPs
represent the group level and the patients stand for individual
level data. The indicators for the three QOF indicator groups
were used as a fixed effect factor. We further used a multilevel
model to fit the three odds ratio data to answer the second part
of the investigation of change over time. We started with the
empty model “no fixed effect” first and then used the QOF
indicator groups factor as fixed covariate.
For hospital attendance, we compared mean attendance of
LES practices with NLES practices, for both a first and follow-
up appointment. We used logistic regression to estimate the
group effect (LES vs. NLES) on the probability of a new and
follow-up hospital appointment.
Results
The effect of LES on QOF indicators in 2009-2010
The percentage achieving the target in the 3 outcomes for
the LES and NLES group are presented in Figure 1. Of all QOF
targets, a lesser percentage of patients achieved the glycemic
target, suggesting that glycaemia needs to be improved upon.
DM12 (BP) shows higher achievement for the NLES group
whereas DM17 (lipid) shows high percentage of achievements
for both groups, although they did not differ significantly. The
median in DM23 (glycaemia), however, was higher for the LES
group practices than the NLES group.
Table 1 presents results of LES and NLES groups cross-
classified by achievement of targets. No statistically significant
observations were obtained for DM12 (BP) and DM17 (lipid).
The difference for DM23 (glycaemia) was, however, statistically
significant (P=0.0001); LES practices were more likely to
achieve the glycemic outcome.
The effect size (the term ‘effect size’ is used generically to
denote the outcome measures DM12, DM17, DM23) (odds
ratio; OR) for the 3 QOF outcomes was not independent.
Figure 1.  Boxplots for DM12(BP), DM17(lipid) and DM23(glycemia) for LES and NLES practices.  
doi: 10.1371/journal.pone.0083738.g001
Table 1. The Odds ratio for the three outcomes, DM12 (BP), DM17 (Lipid) and DM23 (Glycaemia) (2x2 tables).
 DM12 (BP) DM17 (Lipid) DM23 (Glycaemia)
 Pos Neg Pos Neg Pos Neg
LES 10732 2671 11354 2049 7095 6308
NonLES 6174 1449 6404 1219 3319 4304
OR, p-value 0.943 (0.1097) 1.05 (0.1826) 1.459* (0.0001)
CI {0.878 1.013} {0.976 1.140} {1.378 1.544}
doi: 10.1371/journal.pone.0083738.t001
Diabetes Enhanced Service Impact on QOF
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Therefore, the same sample was used to compute 3 ORs for
LES vs. NLES practice achievements. The forest plots in
Figure 2 describe the effect size of each QOF group and
estimate the combination and its confidence interval. DM23
(glycaemia) effect size is positive and significant; the
combination of the 3 outcomes is also positive but not
significant.
Table 2 presents results based on multilevel modeling
approach in which the clustering effect of individual patients
nested into GP practice were considered. The LES has
significant effect on DM23 (glycaemia) measurement (hazard
ratio 1.134;P<0.001) compared to NLES. The probability of
achieving a satisfactory level of DM23 (glycaemia) increases
by almost 10% for LES groups compared with the alternative.
However, the effect of LES on DM12 (BP) and DM17 (lipid)
was not significant.
Figure 2.  Forest plots for the 3 QOF outcomes.  
doi: 10.1371/journal.pone.0083738.g002
The first part of Table 3 shows the general estimate of GP
random effect and fixed effect of the intercept and LES (LES
Model). Compared to individual groups in Table 2, the random
intercept increased dramatically, indicating larger sample size
and higher variance. The fixed intercept was significant and the
LES effect not significant. In the second part (interaction
model) we adjusted for the three QOF outcome groups and
used the intercept at zero to avoid using the first item as the
reference item and the basis for the intercept. There was no
change in random intercept and the log likelihood when running
the second part (interaction model). We had 6 significant
estimates for the interaction of the QOF outcome group type
with the LES indicator. The first three LES coefficients showed
little difference, indicating that the probability of achieving the
target is a function of the interaction of the LES group and the
QOF indicator type.
The second three NLES significant interaction coefficients
reflect similar results. The comparisons between LES and
NLES interaction coefficient clearly show that LES GPs do
better than NLES GPs with a very small margin.
Table 2. Results from fitting logistic multilevel modeling
approach in which the clustering effect of individual patients
nested into GP practice were considered.
Parameter estimate DM12 (BP) DM17 (Lipid) DM23 (Glycaemia)
Random Effects Intercept 0.197 0.164 0.215
Fixed Effects Intercept 1.561 (0.078) 1.690 (0.073) -0.253 (0.078)
Fixed Effects LES -0.117 (0.111) 0.027 (0.104) 0.385 (0.112)
Loglikelihood -10197 -8979 -14144
The LES has significant effect on DM23 (glycaemia) measurement (hazard ratio
1.134;P<0.001) compared to NLES. The effect of LES on DM12 (BP) and DM17
(lipid) was not significant.
doi: 10.1371/journal.pone.0083738.t002
Table 3. The general estimate of GP random effect and fixed effect of the intercept and LES (LES Model; see text).
LES Model Estimate P-value Interaction Model Estimate P-value
Random effects Intercept 1.9675  1.9674
Fixed effects Intercept 1.13573 (0.00001)   
Fixed effects LES -0.03426 (0.91600) DM12*LES 1.1372 (0.000001)
  DM17*LES 1.1343 (0.000001)
  DM23*LES 1.1358 (0.000001)
  DM12*NonLES 1.1015 (0.000001)
  DM17*NonLES 1.0988 (0.000001)
  DM23*NonLES 1.1054 (0.000001)
LogLik -32967 LogLik -32967
The LES has significant effect on DM23 (glycaemia) measurement (hazard ratio 1.134;P<0.001) compared to NLES. The effect of LES on DM12 (BP) and DM17 (lipid) was
not significant.
doi: 10.1371/journal.pone.0083738.t003
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Testing changes over two time points
We compared available data from 34 of the NLES practices
in 2004-2005 as a base compared to 2009-2010 as our
comparison. The CMH test assumes that the odds ratios are
near the same across GPs with asymptotic χ2 distributions.
Thus we rejected the null hypothesis of conditional
independence between the two time points given GP, see
Table 4. The Q test for heterogeneity suggests considerable
heterogeneity among the true performance. It is more
informative to estimate the association than to test the
hypothesis about it.
When modeling the changes over time, we identified a
significant performance difference for DM12 (BP) between
2009-2010 and 2004-2005 (P<0.0001). The combined OR
estimate was 2.27, indicating that achievement of DM12 (BP)
in 2009-2010 is 2.27 times better than achievement in
2004-2005. For DM17 (lipid), we also found a significant
difference between 2009-2010 and 2004-2005 (P<0.0001) and
the combined OR estimate is 2.67 indicating that achievement
of DM17 (lipid) in 2009-2010 is 2.67 times better than
achievement in 2004-2005. With DM23 (glycaemia), there is a
significant drawback in achieving the targets with a combined
odds ratio estimate of 0.64. However, this may be because the
targets for HbA1c are different now compared to 2004-2005.
The targets have been set lower, and are more difficult to
achieve. The results in Table 5 show the common OR estimate
(12).
Table 6 shows the estimate of the multilevel model to fit the
three OR data to answer the second part of the investigation of
change over time. The difference in the loglikelihood of the
empty and covariates model demonstrates improvement in the
fitting with respect to the covariate model.
The inter class correlation (ICC) of covariate model indicates
that 30% of the variation is attributed to GP and 70% are
attributing to individual patients. A significant difference
between the two groups DM12 (BP) and DM23 (glycaemia)
was recognized. The DM12 (BP) parameter estimate of (1.223)
shows significant opposite direction. The DM17 (lipid)
parameter estimate is even higher (1.325).
Diabetes related hospital attendance
For diabetes related hospital appointments, there was a
significant difference between LES and NLES practices, with
LES practices referring fewer patients for hospital
appointments, both for a new appointment and also for follow-
up appointments (Figure 3). The logistic regression estimate of
the group effect (LES vs. NLES) on the probability of a new
appointment is 0.69, i.e. OR is 1.21 higher for NLES compared
to LES group. For the follow-up the probability estimate from
logistic regression is 0.77, i.e. OR is 2.37 higher for NLES
group compared to LES group. The above modeling takes the
effect of one predictor at a time on the logit of the new
appointment and follow-up.
Discussion
To our knowledge this is the first study to undertake a
comparison of quality of care in locally enhanced diabetes
Table 4. Q and CMH test statistic and its P-values (see
text).
Test statistic DM12 (BP) DM17 (Lipid) DM23 (Glycaemia)
Q test of heterogeneity (df) 120.49 (33) 95.28 (33) 136.15 (33)
P-value <0.0001 <0.0001 <0.0001
CMH (df) 379.53 (1) 424.00 (1) 61.10 (1)
P-value <0.0001 <0.0001 <0.0001
doi: 10.1371/journal.pone.0083738.t004
Table 5. Estimate and confidence intervals of common
odds ratio, total amount of heterogeneity (τ2) and
percentage of total variability due to heterogeneity (I2).
Estimator DM12 (BP) DM17 (Lipid) DM23 (Glycaemia)
Common Odds
ratio (C.I)
2.380 (1.962 -
2.890) 2.633 (2.223 - 3.121) 0.709 (0.591 - 0.849)
τ2 (C.I) 0.234 (0.120 -0.486) 0.151(0.061 - 0.314) 0.215 (0.121 - 0.479)
I2 (C.I) 75.35 (60.94 -86.36) 63.67 (41.54 - 78.49) 78.70 (67.56 - 89.16)
doi: 10.1371/journal.pone.0083738.t005
Table 6. Parameters estimate of two multilevel models.
Parameter Empty Model Covariate model
Random Effects- GP 0.0000 0.0926
Residual 0.6704 0.2178
Fixed Effects- Intercept 0.487 (0.081) -0.363 (0.096)
DM12 (BP)  1.223 (0.113)
DM17 (Lipid)  1.325 (0.113)
Loglikelihood -125.4 -83.89
doi: 10.1371/journal.pone.0083738.t006
Figure 3.  Boxplots for hospital first and follow-up
appointments; comparison between LES and NLES
practices.  
doi: 10.1371/journal.pone.0083738.g003
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programmes using QOF indicators. The establishment of local
enhanced services was recommended to improve care for
specific diseases. LES practices were expected to provide all
essential and additional services that they were contracted to
provide for patients with diabetes. The key finding of this study
is that practices in the LES group were achieving significantly
better targets for the QOF indicator DM23 (glycaemia) than
NLES practices. However, there was no significant difference
between DM12 (BP) and DM17 (lipid) indicators between LES
and Non-LES practices.
When we investigated the effects of time on achievement of
target, it was difficult to conduct for DM23 (glycaemia).This was
because in 2004-2005 there was no DM23 indicator. The
closest QOF indicator was DM6, which had a higher HbA1c
target. We identified that these practices were achieving better
HbA1c outcomes in 2004-2005 than in 2009-2010. However,
this may be due to the fact that HbA1c targets are more
stringent in the latter time period, so more difficult to achieve
than in 2004-2005. Over time, there was a significant
improvement over time for DM12 (BP) and DM17 (lipid),
indicating that general performance of practices has improved.
Both of these results support previous research, which also
found that between 1997 and 2005, the proportion of patients
whose blood pressure and cholesterol met national targets
increased in all sized practices [20].
The limitation of our study was that initial analyses
considered only the patient variation and assumed that there
was no variation among GPs, as if all the patients in the three
QOF outcome measures belonged to one GP. The absence of
an important variance component might preclude external
generalizability of the results. Nesting data format can help in
compensating for variance among GPs, i.e. patients nested
within GPs. This new multilevel data structure provided good
ground for running a different type of modeling. Multilevel
models are used to make inference about the relationships
between explanatory variables and response variables within
and among GPs. This type of model simultaneously handles
patient level relationships and takes account of the way
patients are grouped in GPs. We found that the probability of
achieving satisfactory level of DM23 (glycaemia) increases by
almost 10% when GPs belong to LES groups compared with
GPs in NLES groups, although the LES estimate of DM12 (BP)
and DM17 (lipid) was not significant.
Longitudinal follow-up would have helped ascertain the
effectiveness of LES further. However, longitudinal follow-up
requires 3 time points to estimate the intercept and slope. Our
study included 2 time points as this was the data available at
the time of performing the analysis.
For diabetes related hospital appointments, there was a
significant reduction between LES and NLES practices, with
LES practices referring fewer patients for hospital
appointments. One reason for this may be that staff in LES
practices are receiving more training and advice on better
management of their diabetes patients, resulting in a reduction
of complications and need for hospital referral. This is less
likely, given the timeframe examined. The other reason is that
in NLES practices, patients requiring insulin are referred to
hospital for initiation and also follow-up. LES practices are
required to manage patients on insulin, therefore reducing
referral and follow-up appointments. This is also important in
potentially explaining the greater achievement of glycemic
targets by LES practices since glycemic control requires
frequent and closer surveillance that can be provided more
efficiently through local services.
In conclusion, our study shows that further financial
incentivization and training through locally enhanced services
can improve achievement of pay-for-performance glycemic
targets [21], but not blood pressure and lipid targets. Given the
increasing prevalence of diabetes and greater pressures on
secondary care, exploring approaches such as LES should be
examined further longitudinally.
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